1. Home
  2. MNMD vs HRTG Comparison

MNMD vs HRTG Comparison

Compare MNMD & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • HRTG
  • Stock Information
  • Founded
  • MNMD 2019
  • HRTG 2012
  • Country
  • MNMD United States
  • HRTG United States
  • Employees
  • MNMD N/A
  • HRTG N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • HRTG Property-Casualty Insurers
  • Sector
  • MNMD Health Care
  • HRTG Finance
  • Exchange
  • MNMD Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • MNMD 509.2M
  • HRTG 590.0M
  • IPO Year
  • MNMD N/A
  • HRTG 2014
  • Fundamental
  • Price
  • MNMD $9.22
  • HRTG $24.10
  • Analyst Decision
  • MNMD Strong Buy
  • HRTG Buy
  • Analyst Count
  • MNMD 7
  • HRTG 3
  • Target Price
  • MNMD $24.71
  • HRTG $29.00
  • AVG Volume (30 Days)
  • MNMD 1.2M
  • HRTG 356.3K
  • Earning Date
  • MNMD 11-06-2025
  • HRTG 11-05-2025
  • Dividend Yield
  • MNMD N/A
  • HRTG N/A
  • EPS Growth
  • MNMD N/A
  • HRTG 76.20
  • EPS
  • MNMD N/A
  • HRTG 3.47
  • Revenue
  • MNMD N/A
  • HRTG $841,666,000.00
  • Revenue This Year
  • MNMD N/A
  • HRTG $5.15
  • Revenue Next Year
  • MNMD N/A
  • HRTG $6.80
  • P/E Ratio
  • MNMD N/A
  • HRTG $6.93
  • Revenue Growth
  • MNMD N/A
  • HRTG 9.57
  • 52 Week Low
  • MNMD $4.70
  • HRTG $8.70
  • 52 Week High
  • MNMD $11.02
  • HRTG $26.64
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 47.40
  • HRTG 62.14
  • Support Level
  • MNMD $8.70
  • HRTG $21.51
  • Resistance Level
  • MNMD $9.30
  • HRTG $23.48
  • Average True Range (ATR)
  • MNMD 0.58
  • HRTG 0.82
  • MACD
  • MNMD -0.13
  • HRTG 0.26
  • Stochastic Oscillator
  • MNMD 22.41
  • HRTG 79.72

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

Share on Social Networks: